Patent · US Active

Methods for non-invasive assessment of genetic alterations

US11929145B2 · kind B2 · utility

0Cited by
2References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2018
Grant dateMar 12, 2024
Priority date
Expiry dateApr 4, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B20/40
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

Technology provided herein relates in part to methods, processes, machines and apparatuses for non-invasive assessment of genetic alterations. In particular, a method is provided for that includes obtaining a set of sequence reads. The sequence reads each include a single molecule barcode (SMB) sequence that is a non-random oligonucleotide sequence. The method further includes assigning the sequence reads to read groups according to a read group signature. The read group signature comprises an SMB sequence and a start and end position of a nucleic acid fragment from the circulating cell free sample nucleic acid. The sequence reads comprising start and end positions and an SMB sequence similar to the read group signature are assigned to a read group. The method further includes generating a consensus for each read group, and determining the presence or absence of a genetic alteration based on the consensus for each read group.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.